Cargando…

Clinical score for early diagnosis of myotonic dystrophy type 2

INTRODUCTION: Myotonic dystrophy type 2 (DM2) is a rare, multisystemic, autosomal dominant disease with highly variable clinical presentation. DM2 is considered to be highly underdiagnosed. OBJECTIVE: The aim of this study was to determine which symptoms, signs, and diagnostic findings in patients r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanovic, Vukan, Peric, Stojan, Pesovic, Jovan, Tubic, Radoje, Bozovic, Ivo, Petrovic Djordjevic, Ivana, Savic-Pavicevic, Dusanka, Meola, Giovanni, Rakocevic-Stojanovic, Vidosava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925479/ https://www.ncbi.nlm.nih.gov/pubmed/36401657 http://dx.doi.org/10.1007/s10072-022-06507-9

Ejemplares similares

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022)

Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1
por: Peric, Stojan, et al.
Publicado: (2021)

Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells
por: Pešović, Jovan, et al.
Publicado: (2018)

Metabolic impairments in patients with myotonic dystrophy type 2
por: VUJNIC, MILORAD, et al.
Publicado: (2018)

Personality traits in patients with myotonic dystrophy type 2
por: Paunic, Teodora, et al.
Publicado: (2017)

Fatigue in myotonic dystrophy type 1: a seven-year prospective study
por: PERIC, STOJAN, et al.
Publicado: (2019)

Multidimensional aspects of pain in myotonic dystrophies
por: Peric, Marina, et al.
Publicado: (2015)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013)

The Coexistence of Myasthenia Gravis and Myotonic Dystrophy Type 2 in a Single Patient
por: Nikolic, Ana, et al.
Publicado: (2013)

Cognitive Impairment in Myotonic Dystrophy Type 1 Is Associated with White Matter Damage
por: Caso, Francesca, et al.
Publicado: (2014)

Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A
por: Ivanovic, Vukan, et al.
Publicado: (2022)

Molecular Genetics and Genetic Testing in Myotonic Dystrophy Type 1
por: Savić Pavićević, Dušanka, et al.
Publicado: (2013)

Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia
por: PERIC, STOJAN, et al.
Publicado: (2019)

LTBP4, SPP1, and CD40 Variants: Genetic Modifiers of Duchenne Muscular Dystrophy Analyzed in Serbian Patients
por: Kosac, Ana, et al.
Publicado: (2022)

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
por: Wood, Libby, et al.
Publicado: (2018)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
por: Wood, Libby, et al.
Publicado: (2019)

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies
por: MEOLA, GIOVANNI
Publicado: (2013)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Editorial: Beyond Borders: Myotonic Dystrophies–A European Perception
por: Schoser, Benedikt, et al.
Publicado: (2018)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
por: Milic Rasic, V, et al.
Publicado: (2015)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy
por: Stojanov, Aleksandar, et al.
Publicado: (2021)

Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism
por: Meola, Giovanni, et al.
Publicado: (2015)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
por: Gable, Karissa L., et al.
Publicado: (2022)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Respiratory failure in myotonic dystrophy 1
Publicado: (2013)

Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)

Hyperostosis Frontalis Interna in Myotonic Dystrophy
por: Suzuki, Keisuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ehjrfhahvhb310t9l0sq303gpt